casimedicos

Frankly Speaking About Family Medicine Microhematuria and the Right Time to Refer: Guideline Updates – Frankly Speaking Ep 455

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455 Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving…

Read More
https://mcdn.podbean.com/mf/web/qjptkz5ijkb9hkb8/frankly-speaking-ep-455-microhematuria.mp4

MDS Podcast Motor rehabilitation for Parkinson’s disease • 2025 MDS Congress

Rehabilitation for movement disorders, like PD, has become increasingly prevalent for patient care. Prof. Alice Nieuwboer discusses how technology has shaped the field, how neurologists can support patient exercise, and what future updates she looks forward to.

Read More

MDS Podcast Achievements and future goals: An interview with MDS President • 2025 MDS Congress

Dr. Victor Fung reflects on his term as MDS President and his appreciation for the accomplishments that were achieved. He further discusses his future hopes and goals of the Society and the #mdscongress.

Read More

MDS Podcast Current genetic landscape for movement disorders • 2025 MDS Congress

The field of genetics often moves quickly, making it a challenge to stay informed. Dr. Gerard Saranza breaks down the current landscape, new discoveries and technologies, and what changes we can expect in the upcoming years.

Read More

MDS Podcast Updates in tauopathies • 2025 MDS Congress

Dr. Yaroslau Compta discusses how the view of co-pathologies has changed the view of many disorders, including tauopathies. He dives into the current state of clinical trials for PSP and what those results may mean for the future of biomarkers.

Read More

MDS Podcast Disease modification and Parkinson’s disease: Clinical trial design and population selection • 2025 MDS Congress

There have been nearly 30 years of disease modifying trials for PD, but little success. Prof. Tanya Simuni breaks down clinical trial design for a heterogenous disease like PD and discusses the future goals and importance of a biological definition.

Read More

MDS Podcast Current landscape of pediatric movement disorders • 2025 MDS Congress

Due to genetic advancements, the pediatric movement disorder field is ever growing. Dr. Shekeeb Mohammad breaks down the current landscape of the field and how adult neurologists can advance their learning.

Read More

ScienceLink Cobertura ScienceLink Berlín 2025: Highlights día 3

La Dra. Isabel Enríquez, en conjunto con el Dr. DavidJosé Heredia, ambos oncólogos médicos mexicanos, comparten su análisis de losestudios más relevantes presentados durante el tercer día del Congreso Anual dela Sociedad Europea de Oncología Médica 2025, celebrado en Berlín, con base enla información disponible al momento de esta grabación. Los trabajos comentados son: Cáncer de…

Read More